サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1539343

医療用画像機器市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Medical Imaging Equipment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日: | 発行: Persistence Market Research | ページ情報: 英文 143 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
医療用画像機器市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月20日
発行: Persistence Market Research
ページ情報: 英文 143 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界の医療用画像機器市場に関する詳細な調査レポートを発行し、促進要因・動向・機会・課題などの市場力学に関する詳細な洞察を提供しました。本レポートは、特にヘルスケアおよび医療機器業界の利害関係者向けに、市場構造と将来展望の包括的な理解を提供することを目的としています。

主要な洞察

  • 世界市場収益（2022年）：427億米ドル
  • 推定市場金額（2033年）：648億米ドル
  • 世界市場成長率（CAGR 2022年～2033年）：4.7%

医療用画像機器の世界市場 - レポート範囲：

医療用画像機器市場は、様々な疾患や状態の診断やモニタリングに使用される幅広い機器を対象としています。これらには、X線装置、MRIシステム、超音波装置、CTスキャナーなどが含まれます。市場は、特に結核、心血管疾患、整形外科疾患などの早期かつ正確な診断の必要性によって促進されています。

市場成長の促進要因：

結核の増加

結核は依然として世界の主要感染症の1つであり、特に低・中所得国では医療用画像機器に対する大きな需要があります。世界保健機関（WHO）によると、年間約1,000万人が結核を発症し、毎年約150万人の命が奪われています。結核患者の大半は、バングラデシュ、中国、パキスタン、フィリピン、インドネシア、インド、ナイジェリア、南アフリカの8カ国に集中しています。これらの地域で結核の有病率が上昇していることが、結核の診断とモニタリングに不可欠なX線装置とMRI装置の需要を押し上げています。

高齢者人口増加

世界の高齢者人口は、特に新興市場において急速なペースで増加しています。WHOの推計によると、2019年の60歳以上の人口は10億人を超え、2030年には14億人、2050年には20億人に達すると予想されています。高齢化社会は、結核や肺炎などの呼吸器疾患、骨粗鬆症などの整形外科疾患、心血管疾患など、さまざまな健康問題を引き起こしやすくなります。これらの疾患の早期かつ正確な診断の必要性が、医療用画像機器の需要を促進しています。X線、超音波、MRI、CTなどの技術は、こうした加齢に伴う健康問題の診断と管理に不可欠です。

データ管理におけるAIの採用

医療用画像診断への人工知能（AI）の統合は、業界に革命をもたらしています。AI主導のツールは画像診断プロセスの精度と効率を高め、より良い診断と治療計画を可能にしています。医療画像分野でのデータ管理におけるAIの採用は、より正確な画像処理、より迅速な分析、患者転帰の改善を可能にするため、市場成長の原動力になると期待されています。

業界コラボレーションとイノベーション

医療用画像機器市場は、業界全体のコラボレーションやイノベーションからも恩恵を受けています。例えば、2022年1月、O2 Investment Partnersは、Modular Devices, Inc.と協業し、同社の成長を支援し、高度な画像診断モダリティを提供します。こうした提携により、医療用画像処理技術のさらなる進歩が促進され、より身近で効果的なものとなることが期待されます。

市場の課題

高コストとインフラ要件

医療用画像機器市場が直面する大きな課題の1つは、機器とそれをサポートするために必要なインフラのコストが高いことです。MRIやCTスキャナーのような高度な画像処理技術には多額の投資が必要であり、中低所得国では障壁になる可能性があります。さらに、これらの機器のメンテナンスや操作には専門的な技術や設備が必要であり、地域によっては容易に利用できない場合もあります。

規制とコンプライアンスの問題

医療用画像診断の分野では、患者の安全性と機器の有効性を確保するために厳しい規制基準が設けられています。特に新技術の導入や新市場への進出を目指す企業にとって、これらの規制を乗り越えるのは複雑で時間のかかる作業となります。これらの規制を遵守することは不可欠ですが、新技術の採用を遅らせ、市場成長に影響を与える可能性もあります。

本レポートで扱う主要な質問

  • 世界の医療用画像機器市場の成長を促す主要な要因は何か？
  • 先進画像技術の採用を主導している消費者層は？
  • 技術の進歩とAIの統合は競合情勢にどのような影響を与えているか？
  • 世界の医療用画像機器市場における主要企業はどこか、また、市場ポジションを維持するためにどのような戦略を採用しているか？
  • 世界の医療用画像機器市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 製品採用分析
  • 製品のUSP / 特徴
  • 規制状況
  • インストールベースシナリオ
  • 最近承認された製品
  • 製品リコール
  • 技術評価
  • バリューチェーン分析
  • PESTLE分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 機器別
    • モダリティ別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場規模（単位）分析

  • 過去の数量（単位）分析、2019年～2023年
  • 現在および将来の数量（単位）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界市場 - 価格分析

  • 地域別価格分析：製品別
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提

第9章 世界市場の需要（金額10億米ドル）分析

  • 2過去の市場金額（10億米ドル）の分析、019年～2023年
  • 現在および将来の市場金額（10億米ドル）の分析と予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第10章 世界市場分析：機器別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（10億米ドル）と数量（ユニット）の分析：機器別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）と数量（ユニット）の分析と予測：機器別、2024年～2033年
    • コンピュータ断層撮影（CT）システム
    • X線システム
    • MRIシステム
    • 超音波システム
    • 核イメージング装置
    • マンモグラフィー装置
    • 造影剤注入器
    • Cアーム・透視装置
  • 市場の魅力分析：機器別

第11章 世界市場分析：モダリティ別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（10億米ドル）分析：モダリティ別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）の分析と予測：モダリティ別、2024年～2033年
    • スタンドアロンデバイス
    • ポータブルデバイス
    • ハンドヘルドデバイス
  • 市場の魅力分析：モダリティ別

第12章 世界市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（10億米ドル）分析：エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）の分析と予測：エンドユーザー別、2024年～2033年
    • 画像診断センター
    • 外来手術センター
    • 専門クリニック
    • 調査機関
  • 市場の魅力分析：エンドユーザー別

第13章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（10億米ドル）と数量（単位）の分析：地域別、2019年～2023年
  • 現在および将来の市場金額（10億米ドル）と数量（単位）の分析と予測、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 東アジア市場分析

第18章 南アジア市場分析

第19章 オセアニア市場

第20章 中東・アフリカ（MEA）市場分析

第21章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • GE Healthcare
    • Hitachi Medical Corporation
    • Philips Healthcare
    • Siemens Healthineers
    • Toshiba Medical Systems Corporation
    • Esaote SpA
    • Positron Corporation
    • Neusoft Medical Systems
    • Neurologica Corporation
    • Mediso Medical Imaging Systems
    • Digirad
    • SHIMADZU CORPORATION
    • Hologic, Inc.
    • Guerbet SA
    • Bayer AG
    • Mallinckrodt
    • Bracco Imaging SpA
    • Ulrich GmbH &Co. KG
    • Medtron
    • Nemoto Kyorindo Co. Ltd
    • Lemer Pax

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP11215

Persistence Market Research has recently published an in-depth report on the global medical imaging equipment market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the healthcare and medical device industries.

Key Insights:

  • Global Market Revenue (2022): US$ 42.7 Billion
  • Estimated Market Value (2033): US$ 64.8 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 4.7%

Global Medical Imaging Equipment Market - Report Scope:

The medical imaging equipment market covers a broad range of devices used in the diagnosis and monitoring of various diseases and conditions. These include X-ray machines, MRI systems, ultrasound devices, and CT scanners. The market is driven by the need for early and accurate diagnosis, particularly for conditions like tuberculosis, cardiovascular diseases, and orthopedic disorders.

Market Growth Drivers:

Growing Incidences of Tuberculosis (TB)

Tuberculosis (TB) remains one of the leading infectious diseases globally, with significant demand for medical imaging equipment, particularly in low- and middle-income countries. According to the World Health Organization (WHO), around 10 million people develop TB annually, with the disease claiming approximately 1.5 million lives each year. The majority of TB cases are concentrated in eight countries, including Bangladesh, China, Pakistan, the Philippines, Indonesia, India, Nigeria, and South Africa. The rising prevalence of TB in these regions is driving the demand for X-ray and MRI equipment, which are crucial for diagnosing and monitoring the disease.

Rising Geriatric Population

The global geriatric population is increasing at a rapid pace, particularly in emerging markets. According to WHO estimates, there were over 1 billion people aged 60 and above in 2019, with this number expected to reach 1.4 billion by 2030 and 2 billion by 2050. The aging population is more susceptible to a range of health issues, including respiratory diseases (such as tuberculosis and pneumonia), orthopedic conditions (like osteoporosis), and cardiovascular diseases. The need for early and accurate diagnosis of these conditions is driving demand for medical imaging equipment. Technologies such as X-ray, ultrasound, MRI, and CT are essential for diagnosing and managing these age-related health issues.

Adoption of AI in Data Management

The integration of artificial intelligence (AI) into medical imaging is revolutionizing the industry. AI-driven tools are enhancing the accuracy and efficiency of imaging processes, enabling better diagnosis and treatment planning. The adoption of AI in data management within the medical imaging sector is expected to drive market growth, as it allows for more precise imaging, faster analysis, and improved patient outcomes.

Industry Collaborations and Innovations

The medical imaging equipment market is also benefiting from industry-wide collaborations and innovations. For instance, in January 2022, O2 Investment Partners collaborated with Modular Devices, Inc. to support the company's growth and provide advanced imaging modalities. Such partnerships are expected to drive further advancements in medical imaging technology, making it more accessible and effective.

Market Challenges:

High Costs and Infrastructure Requirements

One of the significant challenges facing the medical imaging equipment market is the high cost of devices and the infrastructure needed to support them. Advanced imaging technologies such as MRI and CT scanners require substantial investment, which can be a barrier in low- and middle-income countries. Additionally, the maintenance and operation of these devices require specialized skills and facilities, which may not be readily available in all regions.

Regulatory and Compliance Issues

The medical imaging sector is subject to strict regulatory standards to ensure patient safety and device efficacy. Navigating these regulations can be complex and time-consuming, particularly for companies looking to introduce new technologies or expand into new markets. Compliance with these regulations is essential, but it can also slow down the adoption of new technologies and impact market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global medical imaging equipment market?
  • Which consumer segments are leading the adoption of advanced imaging technologies?
  • How are technological advancements and AI integration influencing the competitive landscape?
  • Who are the key players in the global medical imaging equipment market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global medical imaging equipment market?

Competitive Intelligence and Business Strategy:

Leading players in the global medical imaging equipment market, such as Siemens Healthineers, GE Healthcare, and Philips Healthcare, are focusing on product innovation, strategic collaborations, and expanding their presence in emerging markets. These companies are investing heavily in research and development to create advanced imaging technologies that offer enhanced diagnostic capabilities and better patient outcomes. Partnerships and collaborations are also playing a key role in driving innovation and expanding the reach of these technologies globally.

Key Companies Profiled:

  • GE Healthcare
  • Hitachi Medical Corporation
  • Philips Healthcare
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation
  • Esaote S.p.A
  • Positron Corporation
  • Neusoft Medical Systems
  • Neurologica Corporation
  • Mediso Medical Imaging Systems
  • Digirad
  • SHIMADZU CORPORATION
  • Hologic, Inc.
  • Guerbet SA
  • Bayer AG
  • Mallinckrodt
  • Bracco Imaging S.p.A
  • Ulrich GmbH & Co. KG
  • Medtron
  • Nemoto Kyorindo Co. Ltd
  • Lemer Pax

Key Segments Covered in Medical Imaging Equipment Industry Research

Equipment:

  • Computed Tomography (CT) Systems
  • X-ray Systems
  • MRI Systems
  • Ultrasound Systems
  • Nuclear Imaging Equipment
  • Mammography Equipment
  • Contrast Media Injectors
  • C-Arms & Fluoroscopy Devices

Modality:

  • Stand-Alone Devices
  • Portable Devices
  • Hand-Held Devices

End User:

  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Product USPs/ Features
  • 4.3. Regulatory Landscape
  • 4.4. Install Base Scenario
  • 4.5. Recent Product Approved
  • 4.6. Product Recall
  • 4.7. Technology Assessment
  • 4.8. Value Chain Analysis
  • 4.9. PESTLE Analysis
  • 4.10. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Medical Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising incidence of chronic diseases
    • 5.2.2. Rising Demand in Emerging Economies for Imaging Technologies
    • 5.2.3. Growing Advancements in Maneuverability and Imaging Capabilities
    • 5.2.4. Adoption of alternative techniques
    • 5.2.5. Strategic mergers and acquisitions
    • 5.2.6. Favorable Reimbursement scenario
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Equipment
    • 6.1.2. By Modality
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Volume (in Units) Analysis, 2019-2023
  • 7.2. Current and Future Volume (in Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Equipment

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Equipment, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Equipment, 2024-2033
    • 10.3.1. Computed Tomography (CT) Systems
      • 10.3.1.1. 256-320 slice CT Systems
      • 10.3.1.2. 128-slice CT Systems
      • 10.3.1.3. 64-slice CT Systems
      • 10.3.1.4. 16-slice and below CT Systems
    • 10.3.2. X-ray Systems
      • 10.3.2.1. Analog X-ray Systems
      • 10.3.2.2. Digital X-ray Systems
        • 10.3.2.2.1. Computed Radiography (CR) Systems
        • 10.3.2.2.2. Digital Radiography (DR) Systems
        • 10.3.2.2.3. Retrofit X-ray Systems
    • 10.3.3. MRI Systems
      • 10.3.3.1. 0.7 T MRI Systems
      • 10.3.3.2. 1.5 T MRI Systems
      • 10.3.3.3. 3 T MRI Systems
      • 10.3.3.4. 7 T MRI Systems
      • 10.3.3.5. Others
    • 10.3.4. Ultrasound Systems
      • 10.3.4.1. Black & White Ultrasound Systems
      • 10.3.4.2. Color Doppler Ultrasound Systems
    • 10.3.5. Nuclear Imaging Equipment
      • 10.3.5.1. Positron Emission Tomography (PET) Systems
        • 10.3.5.1.1. PET Scanners
        • 10.3.5.1.2. PET/CT
        • 10.3.5.1.3. PET/MRI
      • 10.3.5.2. Single-Photon Emission Computed Tomography
        • 10.3.5.2.1. Single Imaging Gamma Cameras
        • 10.3.5.2.2. SPECT/CT
    • 10.3.6. Mammography Equipment
      • 10.3.6.1. Film-Screen Mammography Equipment
      • 10.3.6.2. 2D Digital Mammography Equipment
      • 10.3.6.3. 3D Tomosynthesis
    • 10.3.7. Contrast Media Injectors
      • 10.3.7.1. CT Injectors
      • 10.3.7.2. MRI Injectors
      • 10.3.7.3. Cardio Injectors
      • 10.3.7.4. PET Injectors
    • 10.3.8. C-Arms & Fluoroscopy Devices
      • 10.3.8.1. C-Arms Systems
        • 10.3.8.1.1. Full Size C - arms Systems
        • 10.3.8.1.2. Mini C - arms Systems
      • 10.3.8.2. Fluoroscopy Devices
  • 10.4. Market Attractiveness Analysis, by Equipment

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Modality, 2024-2033
    • 11.3.1. Stand-Alone Devices
    • 11.3.2. Portable Devices
    • 11.3.3. Hand-Held Devices
  • 11.4. Market Attractiveness Analysis, by Modality

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 12.3.1. Diagnostic Imaging Centers
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Specialty Clinics
    • 12.3.4. Research Institutes
  • 12.4. Market Attractiveness Analysis, by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Equipment
    • 14.3.3. By Modality
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Equipment
    • 14.4.3. By Modality
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Equipment
        • 14.7.1.2.2. By Modality
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Equipment
        • 14.7.2.2.2. By Modality
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Equipment
    • 15.3.3. By Modality
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Equipment
    • 15.4.3. By Modality
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Mexico Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Equipment
        • 15.7.1.2.2. By Modality
        • 15.7.1.2.3. By End User
    • 15.7.2. Brazil Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Equipment
        • 15.7.2.2.2. By Modality
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Equipment
        • 15.7.3.2.2. By Modality
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Equipment
    • 16.3.3. By Modality
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Equipment
    • 16.4.3. By Modality
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Equipment
        • 16.7.1.2.2. By Modality
        • 16.7.1.2.3. By End User
    • 16.7.2. Italy Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Equipment
        • 16.7.2.2.2. By Modality
        • 16.7.2.2.3. By End User
    • 16.7.3. France Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Equipment
        • 16.7.3.2.2. By Modality
        • 16.7.3.2.3. By End User
    • 16.7.4. U.K. Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Equipment
        • 16.7.4.2.2. By Modality
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.5.2.1. By Equipment
        • 16.7.5.2.2. By Modality
        • 16.7.5.2.3. By End User
    • 16.7.6. Russia Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.6.2.1. By Equipment
        • 16.7.6.2.2. By Modality
        • 16.7.6.2.3. By End User
    • 16.7.7. BENELUX Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.7.2.1. By Equipment
        • 16.7.7.2.2. By Modality
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Equipment
    • 17.3.3. By Modality
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Equipment
    • 17.4.2. By Modality
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Equipment
        • 17.7.1.2.2. By Modality
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Equipment
        • 17.7.2.2.2. By Modality
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.3.2.1. By Equipment
        • 17.7.3.2.2. By Modality
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Equipment
    • 18.3.3. By Modality
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Equipment
    • 18.4.3. By Modality
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Equipment
        • 18.7.1.2.2. By Modality
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Equipment
        • 18.7.2.2.2. By Modality
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Equipment
        • 18.7.3.2.2. By Modality
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Equipment
        • 18.7.4.2.2. By Modality
        • 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Equipment
    • 19.3.3. By Modality
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Equipment
    • 19.4.3. By Modality
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.7.1.2.1. By Equipment
        • 19.7.1.2.2. By Modality
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.7.2.2.1. By Equipment
        • 19.7.2.2.2. By Modality
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Equipment
    • 20.3.3. By Modality
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Equipment
    • 20.4.2. By Modality
    • 20.4.3. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.1.2.1. By Equipment
        • 20.7.1.2.2. By Modality
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkiye Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.2.2.1. By Equipment
        • 20.7.2.2.2. By Modality
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.3.2.1. By Equipment
        • 20.7.3.2.2. By Modality
        • 20.7.3.2.3. By End User
    • 20.7.4. North Africa Market Analysis
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.7.4.2.1. By Equipment
        • 20.7.4.2.2. By Modality
        • 20.7.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis, by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. GE Healthcare
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. Hitachi Medical Corporation
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. Philips Healthcare
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Siemens Healthineers
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. Toshiba Medical Systems Corporation
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Esaote S.p.A
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Positron Corporation
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Strategy Overview
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. Neusoft Medical Systems
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Strategy Overview
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Neurologica Corporation
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Strategy Overview
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. Mediso Medical Imaging Systems
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Strategy Overview
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Digirad
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Financials
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Strategy Overview
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. SHIMADZU CORPORATION
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Financials
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Strategy Overview
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. Hologic, Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Financials
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Strategy Overview
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy
    • 22.3.14. Guerbet SA
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Key Financials
      • 22.3.14.5. SWOT Analysis
      • 22.3.14.6. Strategy Overview
        • 22.3.14.6.1. Marketing Strategy
        • 22.3.14.6.2. Product Strategy
        • 22.3.14.6.3. Channel Strategy
    • 22.3.15. Bayer AG
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Sales Footprint
      • 22.3.15.4. Key Financials
      • 22.3.15.5. SWOT Analysis
      • 22.3.15.6. Strategy Overview
        • 22.3.15.6.1. Marketing Strategy
        • 22.3.15.6.2. Product Strategy
        • 22.3.15.6.3. Channel Strategy
    • 22.3.16. Mallinckrodt
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Sales Footprint
      • 22.3.16.4. Key Financials
      • 22.3.16.5. SWOT Analysis
      • 22.3.16.6. Strategy Overview
        • 22.3.16.6.1. Marketing Strategy
        • 22.3.16.6.2. Product Strategy
        • 22.3.16.6.3. Channel Strategy
    • 22.3.17. Bracco Imaging S.p.A
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Sales Footprint
      • 22.3.17.4. Key Financials
      • 22.3.17.5. SWOT Analysis
      • 22.3.17.6. Strategy Overview
        • 22.3.17.6.1. Marketing Strategy
        • 22.3.17.6.2. Product Strategy
        • 22.3.17.6.3. Channel Strategy
    • 22.3.18. Ulrich GmbH & Co. KG
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Sales Footprint
      • 22.3.18.4. Key Financials
      • 22.3.18.5. SWOT Analysis
      • 22.3.18.6. Strategy Overview
        • 22.3.18.6.1. Marketing Strategy
        • 22.3.18.6.2. Product Strategy
        • 22.3.18.6.3. Channel Strategy
    • 22.3.19. Medtron
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Sales Footprint
      • 22.3.19.4. Key Financials
      • 22.3.19.5. SWOT Analysis
      • 22.3.19.6. Strategy Overview
        • 22.3.19.6.1. Marketing Strategy
        • 22.3.19.6.2. Product Strategy
        • 22.3.19.6.3. Channel Strategy
    • 22.3.20. Nemoto Kyorindo Co. Ltd
      • 22.3.20.1. Overview
      • 22.3.20.2. Product Portfolio
      • 22.3.20.3. Sales Footprint
      • 22.3.20.4. Key Financials
      • 22.3.20.5. SWOT Analysis
      • 22.3.20.6. Strategy Overview
        • 22.3.20.6.1. Marketing Strategy
        • 22.3.20.6.2. Product Strategy
        • 22.3.20.6.3. Channel Strategy
    • 22.3.21. Lemer Pax
      • 22.3.21.1. Overview
      • 22.3.21.2. Product Portfolio
      • 22.3.21.3. Sales Footprint
      • 22.3.21.4. Key Financials
      • 22.3.21.5. SWOT Analysis
      • 22.3.21.6. Strategy Overview
        • 22.3.21.6.1. Marketing Strategy
        • 22.3.21.6.2. Product Strategy
        • 22.3.21.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology